Location History:
- Hørsholm, DK (2006)
- Carina Heights, AU (2010)
Company Filing History:
Years Active: 2006-2010
Title: **Anand Gautam: Innovator in Therapeutic Vaccination**
Introduction
Anand Gautam, based in Carina Heights, Australia, is a distinguished inventor with a focus on therapeutic vaccination. With a portfolio of three patents, Gautam has made significant contributions to immune response methods, particularly in the context of cancer-specific antigens. His innovative approaches aim to enhance cell-mediated immunity and have potential applications in cancer therapy.
Latest Patents
One of Gautam's notable patents involves a method for inducing cell-mediated immunity against cellular antigens. Specifically, this patent outlines a technique for generating cytotoxic T-lymphocyte immunity against weak antigens, including self-proteins. The method incorporates the induction of antigen-presenting cells to present both a CTL epitope of the weak antigen and a foreign T-helper lymphocyte epitope simultaneously. In preferred applications, the targeted antigens are cancer-specific, such as PSM, Her2, or FGF8b. The method can be operationalized through various approaches, including traditional polypeptide vaccination, live attenuated vaccines, or nucleic acid vaccination. Additionally, the invention includes immunogenic analogues of PSM, Her2, and FGF8b, along with nucleic acid molecules encoding these analogues, alongside vectors and transformed cells. Furthermore, the patent outlines a method for identifying immunogenic analogues of weak or non-immunogenic antigens.
Career Highlights
Gautam's career encompasses valuable experience in the biotechnology sector, where he has worked for reputable companies such as Bn Immunotherapeutics, Inc. and Pharmexa A/S. His innovative spirit and dedication to research have placed him at the forefront of developing new therapeutic approaches.
Collaborations
Throughout his career, Anand Gautam has collaborated with notable colleagues, including Lucilla Steinaa and Søren Mouritsen. These partnerships have fostered a stimulating environment for the exchange of ideas and advancements in immunotherapeutic methods.
Conclusion
Anand Gautam's contributions to therapeutic vaccination demonstrate his commitment to advancing cancer treatment through innovation. With his patented methods and collaborative efforts, he continues to play a vital role in the field of immunology, paving the way for future breakthroughs in medical science.